Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Hepatology. 2010 Jan;51(1):121–129. doi: 10.1002/hep.23276

Table 2.

Change in physical and biochemical parameters after 48 weeks of intervention*

Variable Group Baseline End of Study P-value#
Weight (Kg) Control 102.9 (20.2) 102.4 (19.2) 0.005
LS 98.9 (24.5) 90.2 (25.9)
BMI (kg/m2) Control 33.7 (4.7) 33.6 (5.0) 0.004
LS 33.6 (5.3) 30.6 (6.2)
Waist Circ (cm) Control 111.3 (11.2) 111.6 (11.2) 0.004
LS 109.3 (14.3) 101.8 (18.4)
ALT (U/L) Control 85.5 (36.5) 69.0 (38.5) 0.01
LS 84.1 (39.1) 41.7 (20.8)
AST (U/L) Control 66.0 (46.3) 48.0 (17.4) 0.11
LS 56.9 (25.4) 36.7 (15.0)
Glucose
(mg/dL)
Control 152.0 (87.2) 121.4 (37.1) 0.88
LS 121.6 (28.7) 111.7 (22.6)
HbA1C (%0 Control 6.8 (2.5) 6.1 (1.2) 0.52
LS 6.3 (1.0) 5.8 (0.7)
HOMA Control 7.3 (6.2) 7.4 (5.6) 0.37
LS 7.4 (4.6) 5.4 (6.1)
Insulin (μU/ml) Control 20.2 (13.3) 23.2 (13.9) 0.30
LS 23.7 (12.5) 18.5 (18.8)
*

Control group, N=10, LS group, N=20

Data expressed as mean (SD).

#

P-value compares the mean difference between the pre- and post-treatment changes in the variables between the two groups